在接受CAR T细胞治疗的成年人中减轻和管理感染风险
Nadeem Tabbara1, M Veronica Dioverti-Prono2, Tania Jain3
1Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
化学抗原受体T细胞疗法 (CAR-T) 可以导致治疗后几个月的严重感染. 预防,免疫支持和及时评估是缓解这些风险和改善患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 化学抗原受体T细胞疗法 (CAR-T) 已经彻底改变了B细胞恶性瘤治疗.
- 由于长期免疫抑制,CAR-T后的延迟感染带来了显著的患病和死亡风险.
- 了解早期,长期和晚期CAR-T后的感染风险至关重要.
研究的目的:
- 审查目前在CAR-T治疗后缓解感染的策略.
- 突出风险评估和对后CAR-T感染的及时干预的重要性.
- 讨论感染预防和管理的不断发展的方法.
主要方法:
- 审查当前的临床实践和新出现的关于CAR-T相关感染的数据.
- 基于CAR-T后时间表 (早期,长期,晚期) 的感染风险分析.
- 对预防性和治疗性干预措施的评估,以缓解感染.
主要成果:
- 由于多因素免疫抑制,CAR-T后感染是一个重大问题.
- 风险分层和量身定制的干预措施对于管理感染至关重要.
- 预防,生长因子,免疫球蛋白治疗和潜在的再接种疫苗是关键策略.
结论:
- 在CAR-T疗法中减轻感染需要全面和不断发展的方法.
- 个性化风险评估将指导预防和干预策略.
- 持续的研究和数据共享对于完善最佳实践至关重要.
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cytotoxic T Cells-mediated Immune Response
846
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

